Publications
105
Citations
2,612
Est. group size
~8
Recurring co-author estimate
Active years
30
Publishing since 1996
This publication record centers on blood clotting biology, particularly a molecule called tissue factor (a protein that helps trigger blood coagulation) and its role in cancer spread, liver disease, and vascular complications such as those seen in COVID-19. The work also explores potential antibody-based treatments that target tissue factor to make chemotherapy more effective against pancreatic cancer. Note that some listed publications (e.g., on dentistry and ophthalmology) appear unrelated to this core theme and may reflect a shared name with other researchers rather than a single unified research program.
Publication output has grown over the last decade, rising from a low of 1-2 papers per year around 2017-2019 to a more consistent 6-8 papers per year from 2023-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Comparative Study of Amniotic Membrane Fixation Methods in the Treatment of Persistent Corneal Epithelial Defects
Ophthalmology in Russia · 2025
- Managing Gingival Bleeding for Effective Bonding of Orthodontic Retainers//
Journal of Medical and Dental Practice · 2025
- Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer
Cancers · 2025
- Сomparative Study of Amniotic Membrane Fixation Methods in the Treatment of Persistent Corneal Epithelial Defects
Ophthalmology in Russia · 2025
- Comparative study of different methods of amniotic membrane fixation in surgical treatment of persistent epithelial defect of cornea
Modern technologies in ophtalmology · 2025
- Endothelial ENaC-α Restrains Oxidative Stress in Lung Capillaries in Murine Pneumococcal Pneumonia–associated Acute Lung Injury
American Journal of Respiratory Cell and Molecular Biology · 2024
- Abstract A085: First-in-class humanized antibody targeting alternatively spliced tissue factor augments anti-metastatic efficacy of chemotherapy in a preclinical model of pancreatic ductal adenocarcinoma
Cancer Research · 2024
- First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
International Journal of Molecular Sciences · 2024
- First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
UNC Libraries · 2024
- Comparative evaluation of combined and traditional (suture) methods of amnion fixation in surgical treatment of persistent corneal erosion
Modern technologies in ophtalmology · 2024
- Molecular Insights into the MLCK Activation by CaM
Journal of Chemical Information and Modeling · 2023
- Relationship between bite force and electromyographic activity of the temporal and masseter muscles
Journal of Medical and Dental Practice · 2023
- Effect of gender and age on the maximal bite force and the electromyographic activity of the masticatory muscles
Journal of Medical and Dental Practice · 2023
- Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
BMC Gastroenterology · 2023
- An adaptive approach to neoadjuvant therapy to maximize resection rates for pancreatic adenocarcinoma: A phase II trial.
Journal of Clinical Oncology · 2023
- Cancer Research×5
- Biophysical Journal×5
- Journal of Medical and Dental Practice×4
- Laboratory Investigation×2
- Cancers×2
- Bryce A. Kerlin
Medicine · The Ohio State University
- Riten Kumar
Medicine · The Ohio State University
- Vilmarie Rodriguez
Medicine · The Ohio State University
- Thomas Nunn
Medicine · Indiana University
- Sarah H. O’Brien
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile